Tag

Immunoassay

Biomarkers are biological indicators that can be measured to assess the presence, severity, or progress of a disease. In the context of Alzheimer’s disease, biomarkers can include proteins and genetic markers to reflect underlying disease processes. ©shutter2u, ©123RF

Editorial ArticleDrug Discovery & Development

Simoa Technology aims to transform future Alzheimer's disease detection and treatment

Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine

13 Nov 2024

Editorial ArticleLife Sciences

Multiplex immunoassays advance personalized cancer therapy

30 Sept 2024

Product NewsClinical Diagnostics

United expertise for allergy diagnostics

30 Aug 2024

Product NewsClinical Diagnostics

Beckman Coulter expands DxI 9000 Immunoassay Analyzer menu

16 Apr 2024

Webinars

The value of high-sensitivity immunoassay in laboratory medicine: Advancing Healthcare Forum

Dec 17, 2024

Editorial Articles

Biomarkers are biological indicators that can be measured to assess the presence, severity, or progress of a disease. In the context of Alzheimer’s disease, biomarkers can include proteins and genetic markers to reflect underlying disease processes. ©shutter2u, ©123RF

Simoa Technology aims to transform future Alzheimer's disease detection and treatment

13 Nov 2024

Microarray printer

Multiplex immunoassays advance personalized cancer therapy

30 Sept 2024

The tech used by cell and gene therapy scientists

27 Mar 2024

Ultrasensitive immunoassay technology drives blood-based biomarkers for Alzheimer's disease

8 Feb 2024

Industry News

Fujirebio and Agappe collaborate in the field of CLIA-based immunoassay

19 Jan 2024

Fujirebio expands its Alzheimer’s disease test menu

22 Dec 2023

Fujirebio and Sysmex to supply the main raw materials of immunoassay reagents

14 Dec 2023

Fapon launches its most efficient chemiluminescence immunoassay analyzer to date

1 Aug 2023

Latest Videos

Synergy between immunoassay & microbiology solutions improve patient care

Beckman Coulter Diagnostics improves patient care with synergistic immunoassay and microbiology solutions

12 Jun 2024

Resources

Enhanced sensitivity of Beckman Coulter DxI 9000 reduces sample & reagent use

11 Nov 2024

Cell and gene therapy clinical development testing

5 Nov 2024

DxI 9000 analyzer achieves Six Sigma performance for high-sensitivity Troponin I measurement

30 Oct 2024

Breaking barriers in Alzheimer’s research with SPEAR UltraDetect pTau 217

14 Oct 2024

How-to-Buy eBooks

How to Buy Multiplexing Technology

13 Dec 2022